These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 13169176)

  • 41. Synoviorthesis with colloidal 32P chromic phosphate for the treatment of hemophilic arthropathy.
    Cabrini RL; Ubios AM; Silberman FS
    J Bone Joint Surg Am; 1995 May; 77(5):807-8. PubMed ID: 7744908
    [No Abstract]   [Full Text] [Related]  

  • 42. Synoviorthesis with 32P-colloidal chromic phosphate in rheumatoid arthritis--clinical, histopathologic and arthrographic changes.
    Onetti CM; Gutiérrez E; Hliba E; Aguirre CR
    J Rheumatol; 1982; 9(2):229-38. PubMed ID: 7097682
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The measurement of radiation doses from P32 chromic phosphate therapy of the peritoneum using SPECT.
    Ott RJ; Flower MA; Jones A; McCready VR
    Eur J Nucl Med; 1985; 11(8):305-8. PubMed ID: 3878292
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Utilisation of colloidal chromic radiophosphate in the treatment of malignant tumours.
    CHEVALLIER A; BURG C
    Prog Nucl Energy 7 Med Sci; 1956; 1():105-7. PubMed ID: 24544392
    [No Abstract]   [Full Text] [Related]  

  • 45. [The absorption of P32 labeled condensed phosphates by BCG and H 37 strains of Mycobacterium tuberculosis].
    MEISSNER J; LEMKE J
    Z Hyg Infektionskr; 1955; 141(3):249-66. PubMed ID: 13257399
    [No Abstract]   [Full Text] [Related]  

  • 46. Double labelling of sodium monofluorophosphate with P32 and F18.
    ERICSSON Y
    Int J Appl Radiat Isot; 1961 Jul; 10():177-80. PubMed ID: 13697138
    [No Abstract]   [Full Text] [Related]  

  • 47. Distribution of colloidal radioactive chromic phosphate after intracavitary administration in the rat.
    COOPER JA; ZORN EM
    J Lab Clin Med; 1953 Dec; 42(6):867-71. PubMed ID: 13109348
    [No Abstract]   [Full Text] [Related]  

  • 48. Radioactivity in blood and urine following intraperitoneal instillation of chromic phosphate in patients with and without ascites.
    Bakri YN; Given FT
    Am J Obstet Gynecol; 1984 Sep; 150(2):184-8. PubMed ID: 6476040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intraperitoneal radioactive chromic phosphate P 32 in the treatment of ovarian cancer.
    Powell JL; Burrell MO; Kirchner AB
    South Med J; 1987 Dec; 80(12):1513-7. PubMed ID: 3423895
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatic radioautography following intravenous injection of radioactive chromium phosphate as a further contribution to reticulo-endothelial functional tests.
    GABRIELI ER; GOULIAN D; CUTLER JL
    Yale J Biol Med; 1955 Sep; 28(1):63-71. PubMed ID: 13257264
    [No Abstract]   [Full Text] [Related]  

  • 51. [Therapeutic indications for colloidal chromium radiophosphate].
    GUERIN RA
    Sem Hop Ther Paris; 1961 Oct; 37():758-9. PubMed ID: 13902681
    [No Abstract]   [Full Text] [Related]  

  • 52. Radioactive chromic phosphate suspension: studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patients.
    Currie JL; Bagne F; Harris C; Sullivan DL; Surwit EA; Wilkinson RH; Creasman WT
    Gynecol Oncol; 1981 Oct; 12(2 Pt 1):193-218. PubMed ID: 7297930
    [No Abstract]   [Full Text] [Related]  

  • 53. Unit dose dispensing of chromic phosphate P 32 suspension.
    Hung JC
    Am J Hosp Pharm; 1994 Dec; 51(24):3081. PubMed ID: 7856633
    [No Abstract]   [Full Text] [Related]  

  • 54. [Experimental studies and clinical-therapeutic experiences with radioactive phosphate suspensions].
    KUTZIM H
    Arch Klin Exp Dermatol; 1960; 211():364-6. PubMed ID: 14412997
    [No Abstract]   [Full Text] [Related]  

  • 55. Dose estimation to the infant from breast milk following intraperitoneal administration of chromic phosphate 32P for the treatment of early ovarian cancer.
    Sharma SC; Osborne RP; Jose B; Carlson JA
    Health Phys; 1984 Sep; 47(3):452-4. PubMed ID: 6500947
    [No Abstract]   [Full Text] [Related]  

  • 56. [Differences in the incorporation of radioactive phosphate into the nucleotides of desoxyribonucleic acid].
    LANGEN P; LISS E
    Acta Biol Med Ger; 1961; 6():186-8. PubMed ID: 13758824
    [No Abstract]   [Full Text] [Related]  

  • 57. [Contribution to the study of the phosphate of radioactive chrome in the local treatment of tumors].
    NEUKOMM S; LERCH P; PEGUIRON L; RICHARD M
    Acta radiol; 1952 Sep; 38(3):239-44. PubMed ID: 12976181
    [No Abstract]   [Full Text] [Related]  

  • 58. [Study of the distribution in the organs of intravenous injections of radioactive chromium phosphate].
    HERVE A; GOVAERTS J
    Acta radiol; 1951 Apr; 35(4):257-64. PubMed ID: 14837774
    [No Abstract]   [Full Text] [Related]  

  • 59. [Animal experiments on the uptake and distribution of radioactive phosphate].
    FREERKSEN E; MEISSNER J
    Z Gesamte Exp Med; 1953; 120(2):190-214. PubMed ID: 13078826
    [No Abstract]   [Full Text] [Related]  

  • 60. Inhibition of uptake of radioactive phosphate by human erythrocytes in vitro.
    Gourley DR
    Am J Physiol; 1951 Jan; 164(1):213-20. PubMed ID: 14810923
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.